Photo of Wesley Melina, John Mitchell, and Ilka McDonnell

FOR IMMEDIATE RELEASE–February 22, 2024– Athens, Georgia – The Athens Community Career Academy, part of the Clarke County School District, is ushering in a new era of education and community development with its innovative Biotechnology Track. Designed to meet the changing needs of the workforce in Athens, this program aims to prepare high school students for successful careers in the local biotech industry.

The first of its kind in Georgia, the Biotechnology Track is a three-course pathway that equips students with the skills and knowledge to use living organisms and biological processes to solve problems and create useful products in fields like medicine, agriculture, and food science. With the support of Athens-Clarke County Economic Development and local biotech businesses, this program was created for students grades 10-12, aligning with the growing demand in the biomanufacturing and pharmaceutical sectors in Athens.

“Career Pathways offer students choices based on local workforce needs. Our goal is to continue connecting the dots between education, industry, and community, preparing students for successful careers,” says Wesley Mellina, CEO of Athens Community Career Academy.

The creation of this new program began over a year ago, driven by the vision of Ilka McConnell, Director of Economic Development for Athens-Clarke County, and Wesley Mellina, CEO of Athens Community Career Academy, in collaboration with local biotech leaders. By working closely with biotech leaders in the community, the Career Academy ensures that the curriculum meets the needs of the local biotech industry.

“One common concern [with other programs] is the lack of hands-on laboratory experience. This course is designed to better prepare students with practical laboratory skills. However, most importantly this course is designed to instill an enthusiasm for life sciences,” says John Mitchell, CEO of Athens Research and Technology. Over the past eighteen months, Athens Research and Technology has contributed both time and resources, helping to launch and make this program accessible and beneficial for students.

“The talent pipeline John Mitchell has helped us build has been tremendous. Athens Research and Technology really started looking at what level of information is needed to start a career in the industry,” says Ilka McConnell, “They’re doing a standout job at keeping their door open to the workforce and really understanding what level of education is needed to be successful in each role on their team.”

With the introduction of the Biotechnology Track, the Career Academy aims to empower students and inspire parents to see the potential in the Athens community. By offering choices for students at an earlier age and providing internship opportunities, class demonstrations, and industry engagement, the Career Academy strives to create a positive impact and showcase the long-term opportunities available in the biotech industry.

“Athens is a magical place. It’s a beautiful city,” says Ilka McConnell, “We want students to grow their skills, grow their support, and eventually grow their families here.” 

Enrolling now for the 2024 Fall semester, the Biotechnology Track is open to 10th-12th graders and offers a comprehensive pathway for students to gain valuable skills in biotech. Students who complete this program will have the chance to earn the Biotility Biotechnician Assistant certification, which further enhances their career prospects in the field.

Diversity in the biotech industry stands as a cornerstone of the Biotechnology Track’s mission. The Athens Community Career Academy, committed to breaking barriers and fostering inclusivity, provides students with opportunities to explore their interests. Stepping back for a broader perspective, biology emerges as the foundational essence of all life. By raising awareness around diversity in the biotech industry and providing students with opportunities to explore their interests, the Career Academy is paving the way for a brighter future where education, industry, and community come together to create a legacy of empowerment and opportunity for the Athens Community. Image from L to R: Wesley Mellina, John Mitchell, Ilka McConnell

Media Contact:
Sydney Lucero

601-455-8590

Georgia Life Sciences Designates City of Atlanta as Newest BioReady® Community

By Sheran Brown • February 21, 2025
Georgia Life Sciences Designates City of Atlanta as Newest BioReady® Community

Bipartisan PBM Reform Back in Focus as House Committee Plans Hearing

By Sheran Brown • February 20, 2025
A renewed push for prescription drug cost reform is gaining momentum in Congress, with the House Energy and Commerce Committee's health subcommittee planning a hearing on pharmacy benefit manager (PBM) reform for late February. The hearing, to be led by Rep. Buddy Carter (R-Ga.), signals a revival of bipartisan efforts to regulate these pharmaceutical intermediaries. PBMs, which negotiate drug prices for insurers and employers, have become a focal point in the broader discussion of healthcare costs. A previous bipartisan agreement to regulate these entities was crafted by Carter and Rep. Diana DeGette (D-Colo.) in the last Congress, though it ultimately stalled when the larger spending bill it was attached to faced opposition. The reform efforts enjoy broad support from both parties and the president, making it one of the few areas with potential for bipartisan cooperation. However, new complications have emerged as Republicans consider using PBM regulations to generate savings for their broader policy agenda, potentially requiring up to $880 billion in cost reductions. The path forward remains uncertain, with ongoing debates about whether such reforms would qualify for budget reconciliation and whether using PBM regulations as a funding mechanism could derail bipartisan cooperation. Meanwhile, stakeholders continue to disagree on the impact of additional PBM regulation, with pharmaceutical companies arguing that PBMs inflate drug costs while PBMs contend that new regulations would increase prices.

Council on State Biotechnology Associations says NIH funds are a critical component of innovation ecosystem

By Sheran Brown • February 20, 2025
The Council of State Biotechnology Associations (CSBA) has issued a strong warning about proposed cuts to National Institutes of Health (NIH) funding, emphasizing the critical role these grants play in America's biotech innovation ecosystem. The statement, below , comes amid concerns over recent guidance that would reduce NIH funding to key research institutions. ----------------------- “Today, the US biotech industry employs nearly 2.3 million people across the US and is making positive contributions to economic impact and national security across all 50 states. In fact, for every dollar the National Institutes of Health (NIH) contributes to a successful drug, the private sector invests over $65, underscoring the agency’s unparalleled return on investment. As the associations representing the bioscience industry across the nation, the Council on State Biotechnology Associations (CSBA) is concerned by recent guidance that would cut funding provided by the NIH to universities, hospitals, and other institutions that perform critical early-stage research. NIH grant funds are a critical component of our innovation ecosystem. Grants for basic research are the spark that leads to university-driven discoveries, with public-private partnerships and tech transfers that bridge early-stage research to industry-sponsored drug development and ultimately to FDA approved medical advances for hundreds of diseases. While the administration looks for greater efficiency in the use of taxpayer dollars, it cannot be overstated - once scientific innovation moves abroad, it may never return. In the race for scientific innovation around the world, as our adversaries continue to increase government investments in research, we encourage President Trump to follow suit and ensure that we maintain our global leadership in an industry that was created and thrives across the US.”
MORE POSTS
Share by: